Schonfeld Strategic Advisors LLC Provention Bio, Inc. Transaction History

Schonfeld Strategic Advisors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$6.7 - $24.21 $960,981 - $3.47 Million	-143,430 Reduced 46.79%	163,116 $3.93 Million
Q4 2022 Feb 14, 2023	BUY	$4.52 - $10.57 $1.39 Million - $3.24 Million	306,546 New	306,546 $3.24 Million
Q3 2021 Nov 16, 2021	SELL	$5.66 - $8.33 $216,257 - $318,272	-38,208 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$6.71 - $11.04 $471,263 - $775,372	-70,233 Reduced 64.77%	38,208 $322,000
Q1 2021 May 17, 2021	BUY	$10.12 - $19.45 $1.1 Million - $2.11 Million	108,441 New	108,441 $1.14 Million
Q3 2019 Nov 14, 2019	SELL	$6.83 - $13.0 $159,139 - $302,900	-23,300 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$2.3 - $13.79 $53,589 - $321,307	23,300 New	23,300 $282,000

170K

Ticker PRVB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,549,904
Description
Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.